POSA128 Cost-Effectiveness Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as a First-Line (1L) Maintenance Treatment for Patients With Locally Advanced or Metastatic Urothelial Carcinoma in Taiwan
Abstract
Authors
WC Chang Y Xiao AY Lin PJ Su C Goh E Wu K Liu P Chou K Kuo R Palencia J Chang M Kearney V Kapetanakis Á Benedict